Literature DB >> 17572677

Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population.

Anja Hoffmann1, Sheena Kerr, Julia Jellusova, Jiquan Zhang, Florian Weisel, Ute Wellmann, Thomas H Winkler, Burkhard Kneitz, Paul R Crocker, Lars Nitschke.   

Abstract

B1 cells are an important cell population for the production of natural antibodies and for antibacterial immunoglobulin responses. Here we identified the mouse protein Siglec-G as a B1 cell inhibitory receptor. Siglec-G was expressed in a B cell-restricted way, with large amounts present in B1 cells. When overexpressed, Siglec-G inhibited B cell receptor-mediated calcium signaling. Siglec-G-deficient mice had massive expansion of the B1a cell population, which began early in development and was B cell intrinsic. Siglec-G-deficient mice had higher titers of natural IgM antibodies but not a higher penetrance of IgG autoantibodies. Siglec-G-deficient B1 cells showed a strongly enhanced calcium signaling. Our results demonstrate that Siglec-G-dependent negative regulation exists in B1 cells, which may explain the naturally muted signaling response of B1 cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17572677     DOI: 10.1038/ni1480

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  86 in total

Review 1.  Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?

Authors:  Huan Cao; Paul R Crocker
Journal:  Immunology       Date:  2010-11-11       Impact factor: 7.397

Review 2.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

Review 3.  The role of B-1 cells in inflammation.

Authors:  Monowar Aziz; Nichol E Holodick; Thomas L Rothstein; Ping Wang
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

Review 4.  Siglecs as sensors of self in innate and adaptive immune responses.

Authors:  James C Paulson; Matthew S Macauley; Norihito Kawasaki
Journal:  Ann N Y Acad Sci       Date:  2012-01-30       Impact factor: 5.691

5.  Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22.

Authors:  Fabian Pfrengle; Matthew S Macauley; Norihito Kawasaki; James C Paulson
Journal:  J Immunol       Date:  2013-07-08       Impact factor: 5.422

6.  SIGLEC-G deficiency increases susceptibility to develop B-cell lymphoproliferative disorders.

Authors:  Giorgia Simonetti; Maria Teresa Sabrina Bertilaccio; Tania Veliz Rodriguez; Benedetta Apollonio; Antonis Dagklis; Martina Rocchi; Anna Innocenzi; Stefano Casola; Thomas H Winkler; Lars Nitschke; Maurilio Ponzoni; Federico Caligaris-Cappio; Paolo Ghia
Journal:  Haematologica       Date:  2014-05-23       Impact factor: 9.941

Review 7.  The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease.

Authors:  Jennifer Müller; Lars Nitschke
Journal:  Nat Rev Rheumatol       Date:  2014-04-29       Impact factor: 20.543

8.  Siglec-G represses DAMP-mediated effects on T cells.

Authors:  Tomomi Toubai; Corinne Rossi; Katherine Oravecz-Wilson; Cynthia Zajac; Chen Liu; Thomas Braun; Hideaki Fujiwara; Julia Wu; Yaping Sun; Stuart Brabbs; Hiroya Tamaki; John Magenau; Pang Zheng; Yang Liu; Pavan Reddy
Journal:  JCI Insight       Date:  2017-07-20

Review 9.  Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.

Authors:  B S Bochner
Journal:  Clin Exp Allergy       Date:  2009-03       Impact factor: 5.018

Review 10.  Basic and clinical immunology of Siglecs.

Authors:  Stephan von Gunten; Bruce S Bochner
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.